UK agency Aurora promotes Chris Bath to managing directorIndependent UK comms agency Aurora has promoted Chris Bath to managing director. In a statement the London-based agency Share XUK agency Aurora promotes Chris Bath to managing directorhttps://pharmaphorum.com/news/uk-agency-aurora-promotes-chris-bath-to-managing-director/
New CEO Mortazavi takes UK biotech e-therapeutics into gene silencingUK biotech e-therapeutics has a new CEO, with executive chairman and former Silence Therapeutics chief Ali Mortazavi chosen Share XNew CEO Mortazavi takes UK biotech e-therapeutics into gene silencinghttps://pharmaphorum.com/news/new-ceo-mortazavi-takes-e-therapeutics-into-gene-silencing/
Sanofi appoints new chief digital officer in C-Suite revampSanofi’s new CEO Paul Hudson has completed his revamp of the company’s executive committee, including the appointment of Share XSanofi appoints new chief digital officer in C-Suite revamphttps://pharmaphorum.com/news/sanofi-appoints-new-chief-digital-officer-in-management-revamp/
Roche’s CMO Horning to retire, Lilly’s high-flyer Garraway steps inRoche’s influential chief medical officer Sandra Horning is to retire at the end of the year, the company Share XRoche’s CMO Horning to retire, Lilly’s high-flyer Garraway steps inhttps://pharmaphorum.com/news/roches-cmo-horning-to-retire/
Gilead’s R&D chief to step down as new CEO O’Day rings the changesGilead’s chief scientific officer, John McHutchison is to leave the company at the beginning of next month during Share XGilead’s R&D chief to step down as new CEO O’Day rings the changeshttps://pharmaphorum.com/news/gileads-rd-chief-to-step-down-as-new-ceo-oday-rings-the-changes/
Cancer doctor Sharpless to take reins at FDA next monthThe director of the US National Cancer Institute, Norman “Ned” Sharpless has been announced as the acting FDA Share XCancer doctor Sharpless to take reins at FDA next monthhttps://pharmaphorum.com/news/cancer-doctor-sharpless-to-take-reins-at-fda-next-month/
GSK’s chairman Sir Philip Hampton steps downGlaxoSmithKline is searching for a new chairman after Sir Philip Hampton announced he is to step down in Share XGSK’s chairman Sir Philip Hampton steps downhttps://pharmaphorum.com/news/gsks-chairman-sir-philip-hampton-steps-down/
Solomon quits as Akari CEO following credit card probeBiotech veteran quits after less than a year in charge Share XSolomon quits as Akari CEO following credit card probehttps://pharmaphorum.com/news/solomon-quits-as-akari-ceo-following-credit-card-probe/
After missing out on CEO job, Novo’s US head quitsThe pressure on Novo Nordisk’s diabetes portfolio is mounting in the US – and the situation seems even Share XAfter missing out on CEO job, Novo’s US head quitshttps://pharmaphorum.com/news/missing-ceo-job-novos-us-head-quits/